Daniel Rodrigues de Bastos
← Back to Universidad Privada del Este
Universidad Privada del Este
Daniel Rodrigues de Bastos works in Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer-related molecular mechanisms research, Cervical Cancer and HPV Research, MicroRNA in disease regulation. Recorded institutional associations include Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors
2020 · 23 citationsThe expression patterns and prognostic significance of pleckstrin homology-like domain family A (PHLDA) in lung cancer and malignant mesothelioma
2021 · 17 citationsPrognostic and Predictive Value of Pleckstrin Homology-Like Domain, Family A Family Members in Breast Cancer
2020 · 12 citationsCD40/CD40L expression and its prognostic value in cervical cancer
2023 · 9 citationsAn In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients
2020 · 7 citationsHigh Levels of Superoxide Dismutase 2 Are Associated With Worse Prognosis in Patients With Breast Cancer
2024 · 6 citationsRISK FACTORS RELATED TO BREAST CANCER DEVELOPMENT
2019 · 4 citationsPrognostic value of Maspin protein level in patients with triple negative breast cancer
2024 · 3 citationsComputational insights into CRISP3 downregulation in cervical cancer and its cervical lineages pattern
2024 · 3 citationsPadrão de metástase no câncer de mama triplo negativo
2017 · 2 citationsROPN1 Gene Expression as a Prognostic and Predictive Biomarker in Aggressive Breast Cancer: Clinical Implications and Survival Association
2025 · 1 citationsTargeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma
2026 · 1 citationsAnálise da expressão de miR-10b e miR-7 potencialmente associados à expressão de BRCA1 em carcinomas de mama
2017 · 0 citationsBRCA1 AND microRNAs 7, 10B, 205ab, 218ª expression as prognostic markers in primary breast cancers – a retrospective cohort study
2018 · 0 citationsThe long non-coding RNA ADAMTS9-AS2 was identified as a potential prognostic biomarker in triple-negative breast cancer
2020 · 0 citationsOncology and Hematology in the ICU
2022 · 0 citationsAnnexin A1 Regulates Retinal Gliosis in Diabetic Retinopathy
2023 · 0 citationsAltered Expression of CYSLTR1 is Associated With Adverse Clinical Outcome in Triple Negative Breast Tumors: An In Silico Approach
2023 · 0 citationsEstudo do receptor Frizzled classe 9 (FZD9), um potencial biomarcador prognóstico e alvo terapêutico
2023 · 0 citationsStudy of Frizzled receptor class 9 (FZD9), a potential prognostic biomarker and therapeutic target
2023 · 0 citationsAuthor response for "Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinoma"
2025 · 0 citationsAssociation of NK6 homeobox 1 promoter methylation with HPV infection, histological sub-type, and patient outcomes in cervical lesions
2026 · 0 citationsFrizzled‐9 Expression Is Associated With Aggressive Clinicopathological Features and Reduced Overall Survival in Invasive Breast Carcinoma
2026 · 0 citationsEvaluation of cytokine release syndrome in non-Hodgkin lymphoma therapy with bispecific antibodies: A meta-analysis of clinical trials
2026 · 0 citationsAnnexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy
2026 · 0 citations
